Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience.
BACKGROUND: Acute ischaemic stroke is common in older people. There is one licensed acute treatment, intravenous recombinant tissue plasminogen activator, but little information is available on its safety in over 80 year olds. DESIGN: Review of prospectively collected data on 62 consecutive patient...
Հիմնական հեղինակներ: | Simon, J, Sandler, D, Pexman, J, Hill, MD, Buchan, A |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2004
|
Նմանատիպ նյութեր
-
Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke.
: Balami, J, և այլն
Հրապարակվել է: (2013) -
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
: Tanne, D, և այլն
Հրապարակվել է: (2002) -
Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block
: AR, Siti Noor Atikah, և այլն
Հրապարակվել է: (2022) -
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.
: Harston, G, և այլն
Հրապարակվել է: (2010) -
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: A review of rtPA neurotoxicity
: Harston, G, և այլն
Հրապարակվել է: (2010)